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SUMMARY
A pilot programme for assessing laboratory perfor­
mance in clinical chemistry laboratories in Zimbabwe 
is described (ZEQAS). Twenty four laboratories pro­
viding patient care services participated. Eightlyphilised 
bovine sera were distributed over one year.
Consensus values and the spread of interlaboratory 
agreement were calculated for each of 12 analytes and 
compared with results previously obtained in a large 
mature national EQA scheme in the UK (UK NEQAS). 
For all analytes except phosphate, the mean consensus 
value obtained in ZEQAS was between 94 and 108 pc 
of the UK target, although the spread of results in 
ZEQAS was generally two to threefold greater for 
individual analytes than in UK NEQAS.
It is concluded that the ZEQAS consensus values for 
the analytes surveyed provide a valid target against 
which individual laboratory performance can be as­
sessed. The wide spread of results from individual 
laboratories suggests there is considerable scope for 
improving interlaboratory agreement. This is being 
addressed by the continuing programme, with increased 
interaction and production of local specimens.
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INTRODUCTION
Laboratory results have an important role in the provi­
sion of optimal health care whether for screening, 
diagnosis, prognosis or monitoring of disease. To ful­
fill this role, results must be accurate (ie. precise and 
unbiased) and comparable between different laborato­
ries.
Clinical laboratories seek to achieve these goals 
through quality assurance programmes which include 
pie-analytical (specimen handling), analytical, and post 
analytical (interpretive) elements of performance.2 As­
sessment of analytical quality requires internal quality 
control (IQC) and external quality assessment (EQA). 
Internal quality control is primarily useful for assessing 
in real time when the test results from an individual 
laboratory can be released for patient care. The main 
focus in IQC is on reproducibility (precision) of results. 
In contrast, EQA examines comparability of results 
between laboratories and can provide valuable infor­
mation on systematic bias of results.12 EQA is neces­
sarily retrospective and requires an overall target value 
against which individual laboratory results can be 
compared.3*6
In Zimbabwe, clinical chemistry laboratories rou­
tinely employ IQC and some participate in commercial 
EQA schemes organised internationally. However, 
such EQA schemes are not ideal for a developing 
country such as Zimbabwe because:
1. The time interval for feedback of the data analysis 
to participating laboratories is too long to be prac­
tically useful in stimulating improved performance.
2. Since the EQA centre is remote, participants find it 
difficult and expensive to seek advice and assis­
tance.
3. Commercial schemes cannot provide impartial ad­
vice with knowledge of local conditions.
4. International commercial schemes are expensive 
and require scarce foreign currency.
5. International commercial schemes cannot provide 
information focused on the quality of performance 
over a whole country.
6. Local priorities cannot be addressed since the scheme 
design is inflexible.
The Zimbabwe EQA scheme in clinical chemistry 
was initiated to survey the comparability of results 
between clinical laboratories. The scheme aims to 
stimulate improved performance by encouraging good
practice and discovering unsatisfactory procedures. As 
a first step, reliable and valid target values for analytes 
in the material distributed are required.
To test the validity of ZEQAS consensus values 
(derived from a relatively small number of laborato­
ries) as targets, they were compared with those ob­
tained from the same material in a mature and large 
clinical UK scheme. The initial surveys also provided 
valuable baseline information on the state of the art in 
Zimbabwe, against which future progress can be as­
sessed.
MATERIALS AND METHODS
Participants: Twenty four clinical chemistry labora­
tories were recruited into the ZEQAS. Three private 
laboratories participated, the others being Public Health 
Laboratories attached to Government hospitals at pro­
vincial level and above.
Specimens: A total of eight distributions constituted 
the pilot phase of the ZEQAS over a period of one year. 
Each distribution included a different lyophilised bo­
vine serum supplied from the UK National External 
Quality Assessment Scheme (UK NEQAS) based at 
Queen Elizabeth Medical Centre, Birmingham. These 
specimens covered a wide range of normal and patho­
logical concentrations for all analytes. All materials 
had been previously distributed in the UK NEQAS, and 
data analysed based on returns from the 650 partici­
pants, yielding results from 300 to 650 laboratories, 
depending on analyte. Locally produced liquid speci­
mens7 were also distributed in the scheme, but data are 
not considered here.
D istribu tion  of specim ens: Vials containing 
lyophilised specimens for reconstitution with five or 10 
ml water were labelled with the distribution number, 
reconstruction instructions and the latest date for re­
ceipt of results by the organisers. Each vial was placed 
in an addressed envelope before transfer to the Public 
Health Laboratories (PHL) at Parirenyatwa Hospital 
for onward delivery by courier, car or post as appropri­
ate. The specimens reached their destination within 24 
hours.
Analysis of specimens and reporting results: The 
specimen was reconstituted in distilled or deionised 
water (five or 10 ml) before analysis. The reconstituted 
specimen was treated and analysed in the same way as 
patients’ specimens. The results of the analyses were 
returned to the organising centre by post After data
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processing, individual laboratory reports were returned 
to the participants together with the next specimen for 
analysis. Each laboratory received an individual confi­
dential report comparing its results with the overall 
data. No laboratory received information on the perfor­
mance of another identifiable laboratory, though re­
ports showed grouped and mean data for all partici­
pants.
Data processing and assessment of performance:
A microcomputer employing a modified MUMPS 
programme (developed and donated by the Wolfson 
Research Laboratories, Queen Elizabeth Medical Cen­
tre, Birmingham, UK) was used for scheme adminis­
tration and statistical analysis of the data. Laboratory 
results received by the organisation on or before the due 
data were processed and files updated accordingly. The 
results, in molar SI units, were entered into the com­
puter by two people independently.
The results were analysed and assessed using con­
sensus values for each analyte. The consensus values 
were recalculated means obtained after elimination of 
outliers by truncation of values greater than 3SD from 
the untrimmed mean.6'8 Reports also showed data 
classified according to the method used, but these were 
not used as targets.
RESULTS
The ratio of consensus values, ZEQAS x 100 pc
UKNEQAS
were calculated for each analyte and each specimen. 
The average ratios in Table I show that there is excel­
lent agreement between the ZEQAS and UK NEQAS 
for most analytes. The ZEQAS results for phosphate 
show over estimation (108,7pc) whereas those for 
glucose and urea indicate a rather wide variation of 
results, due to the spread of inter laboratory agreement 
(Table II) and the small number of participants.810
The inter-laboratory agreement for each analyte in 
the sample distributed was quantified by calculating 
the coefficient of variation (CV, pc) of the results from 
the laboratories. Table II compares inter laboratory 
agreement in the ZEQAS and UK NEQAS. Taking the 
UK NEQAS values as a target obtained from more than 
300 laboratories, the ZEQAS perfonnance shows be­
tween two and threefold greater spread of results. Only 
sodium, potassium, glucose and total protein have 
average CV values below 10. The greatest variation
Table I: Comparison o f consensus values in ZEQAS 
and UK NEQAS o f the eight lyophilized specimens.
Number of participants: Zimbabwe = 24; UK » 300 to 620
Analyte ZEQAS/UK NEQAS Range* SO
Average (pc)
Sodium 99,6 98,4 — 101,0 1,09
Potassium 99,5 97,2 — 102,0 1.57
Urea 95,7 90,0 — 98,2 3,29
Glucose 94,4 88,0 — 98,7 3,32
Calcium 96,7 87,0 — 109,0 6,68
Phosphate 108,7 91,0 — 132,6 12,89
Urate 103,4 97,1 — 113,8 6,26
Creatine 97,8 89,0 — 103,0 5,84
Bilirubin 107,2 92,0 — 108,0 5,21
Total protein 97,7 94,8 — 100,8 2,85
Cholesterol 96,9 88,0 — 107,0 5,55
*  Range o f ratio$ obtained fo r all distribution*.
Table II: Comparison o f Interlaboratory Agreement 
(Average CV, pc fo r  each analyte in the eight 
samples distributed) obtained in ZEQAS and UK 
NEQAS.
Number of participants: Zimbabwe = 24: UK *  between 300 to 620 
depending on analyte.
ZEQAS UKNEQAS
Analyte Average CV, 
pc
SO Average CV, 
PC
SD
Sodium (mmol/l) 2,28 0,7 1,40 0,2
Potassium (mmol/l) 3,28 0,8 2,44 0,3
Urea (mmol/l) 11,04 0.3 4,60 0,9
Glucose (mmol/l) 8,04 3,4 4,04 0,4
Calcium (mmol/l) 19,78 5,0 3,16 0,4
Phosphate (mmol/l) 19,78 5,6 4,75 0,4
Urate (mmol/l) 14,44 4,3 6,20 0.5
Creatine (mol/l) 11,60 9,5 8,40 0,5
Bilirubin (mol/l) 17,74 9,0 8,40 1,3
Total protein (g/l) 7,44 1,4 3,24 0,4
Cholesterol (mmol/l) 12,60 4,6 4,35 0,1
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relative to UK NEQAS was found for calcium, phos­
phate and cholesterol, though the high CV for choles­
terol in ZEQAS is due in part to use of chemical and 
enzymic methods which have differing specificity.
DISCUSSION
Hie UK NEQAS has been operating successfully for 
over 20 years, and this is frequently used as the refer­
ence for other schemes.*-9 In this pilot ZEQAS, the UK 
procedures for statistical calculations were adopted 
and consensus values for UK NEQAS were used as 
targets, against which to compare the ZEQAS results.
The results demonstrate that there is close agreement 
between the consensus values obtained from ZEQAS 
and UK NEQAS despite the relatively small number of 
participants in the Zimbabwe scheme (24), compared 
to the UK scheme (300 to 620 depending on analyte). 
Difference for glucose and phosphate may be due to 
changes in specimen composition if the delay between 
reconstitution and analysis is excessive: the large be­
tween laboratory CV for phosphate supports this pos­
sibility. The inter laboratory agreement, however, leaves 
substantial scope for improvement. It is important to 
emphasise that no counselling of laboratories was done 
during this pilot programme.
It is concluded that the consensus values in the 
ZEQAS have been validated as suitable targets against 
which individual laboratory performance can be as­
sessed. Since this pilot programme, ZEQAS has been 
expanded and operated independently of the UK 
NEQAS, with a system for providing advice and assis­
tance to participants with apparent performance prob­
lems. Future publications will report on the validation 
of locally produced liquid bovine serum specimens and 
changes in laboratory performance over time in ZEQAS.
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